Middle East respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling.
Identifieur interne : 000017 ( PubMed/Curation ); précédent : 000016; suivant : 000018Middle East respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling.
Auteurs : Chi-You Chang [Taïwan] ; Helene Minyi Liu [Taïwan] ; Ming-Fu Chang [Taïwan] ; Shin C. Chang [Taïwan]Source :
- Journal of virology [ 1098-5514 ] ; 2020.
Abstract
Type I and type III interferons (IFNs) are the frontlines of antiviral defense mechanism that trigger hundreds of downstream antiviral genes. In this study, we observed that MERS-CoV nucleocapsid (N) protein suppresses type I and III IFN gene expression. The N protein suppresses Sendai virus-induced IFN-β and IFN-λ1 by reducing their promoter activity and mRNA levels as well as downstream IFN stimulated genes (ISGs). Retinoic acid-inducible gene-I (RIG-I) is known to recognize viral RNA and induce IFN expression through tripartite motif-containing protein 25 (TRIM25)-mediated ubiquitination of RIG-I caspase activation and recruitment domains (CARDs). We discovered that MERS-CoV N protein suppresses RIG-I-CARD-, but not MDA5-CARD-induced IFN-β and IFN-λ1 promoter activity. By interacting with TRIM25, N protein impedes RIG-I ubiquitination and activation and inhibits the phosphorylation of transcription factors IFN-regulatory factor 3 (IRF3) and NF-κB that are known to be important for IFN gene activation. By employing recombinant Sindbis virus-EGFP replication system, we showed that viral N protein downregulated the production of not only IFN mRNA but also bioactive IFN proteins. Taken together, MERS-CoV N protein functions as an IFN antagonist. It suppresses RIG-I-induced type I and type III IFN production by interfering with TRIM25-mediated RIG-I ubiquitination. Our study sheds light on the pathogenic mechanism of how MERS-CoV causes disease.IMPORTANCE MERS-CoV causes death of about 35% of patients. Published studies showed that some coronaviruses are capable of suppressing interferon (IFN) expression in the early phase of infection and MERS-CoV proteins can modulate host immune response. In this study, we demonstrated that MERS-CoV nucleocapsid (N) protein suppresses the production of both type I and type III IFNs via sequestering TRIM25, an E3 ubiquitin ligase that is essential for activating RIG-I signaling pathway. Ectopic expression of TRIM25 rescues the suppressive effect of the N protein. In addition, the C-terminal domain of the viral N protein plays a pivotal role in the suppression of IFN-β promoter activity. Our findings reveal how MERS-CoV evades innate immunity and provide insights into the interplay between host immune response and viral pathogenicity.
DOI: 10.1128/JVI.00099-20
PubMed: 32295922
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000017
Links to Exploration step
pubmed:32295922Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Middle East respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling.</title>
<author><name sortKey="Chang, Chi You" sort="Chang, Chi You" uniqKey="Chang C" first="Chi-You" last="Chang">Chi-You Chang</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.</nlm:affiliation>
<country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Institute of Microbiology, National Taiwan University College of Medicine, Taipei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Liu, Helene Minyi" sort="Liu, Helene Minyi" uniqKey="Liu H" first="Helene Minyi" last="Liu">Helene Minyi Liu</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan.</nlm:affiliation>
<country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chang, Ming Fu" sort="Chang, Ming Fu" uniqKey="Chang M" first="Ming-Fu" last="Chang">Ming-Fu Chang</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan mfchang@ntu.edu.tw.</nlm:affiliation>
<country wicri:rule="url">Taïwan</country>
<wicri:regionArea>Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chang, Shin C" sort="Chang, Shin C" uniqKey="Chang S" first="Shin C" last="Chang">Shin C. Chang</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan scchang093@ntu.edu.tw.</nlm:affiliation>
<country wicri:rule="url">Taïwan</country>
<wicri:regionArea>Institute of Microbiology, National Taiwan University College of Medicine, Taipei</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32295922</idno>
<idno type="pmid">32295922</idno>
<idno type="doi">10.1128/JVI.00099-20</idno>
<idno type="wicri:Area/PubMed/Corpus">000017</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000017</idno>
<idno type="wicri:Area/PubMed/Curation">000017</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000017</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Middle East respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling.</title>
<author><name sortKey="Chang, Chi You" sort="Chang, Chi You" uniqKey="Chang C" first="Chi-You" last="Chang">Chi-You Chang</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.</nlm:affiliation>
<country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Institute of Microbiology, National Taiwan University College of Medicine, Taipei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Liu, Helene Minyi" sort="Liu, Helene Minyi" uniqKey="Liu H" first="Helene Minyi" last="Liu">Helene Minyi Liu</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan.</nlm:affiliation>
<country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chang, Ming Fu" sort="Chang, Ming Fu" uniqKey="Chang M" first="Ming-Fu" last="Chang">Ming-Fu Chang</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan mfchang@ntu.edu.tw.</nlm:affiliation>
<country wicri:rule="url">Taïwan</country>
<wicri:regionArea>Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chang, Shin C" sort="Chang, Shin C" uniqKey="Chang S" first="Shin C" last="Chang">Shin C. Chang</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan scchang093@ntu.edu.tw.</nlm:affiliation>
<country wicri:rule="url">Taïwan</country>
<wicri:regionArea>Institute of Microbiology, National Taiwan University College of Medicine, Taipei</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Type I and type III interferons (IFNs) are the frontlines of antiviral defense mechanism that trigger hundreds of downstream antiviral genes. In this study, we observed that MERS-CoV nucleocapsid (N) protein suppresses type I and III IFN gene expression. The N protein suppresses Sendai virus-induced IFN-β and IFN-λ1 by reducing their promoter activity and mRNA levels as well as downstream IFN stimulated genes (ISGs). Retinoic acid-inducible gene-I (RIG-I) is known to recognize viral RNA and induce IFN expression through tripartite motif-containing protein 25 (TRIM25)-mediated ubiquitination of RIG-I caspase activation and recruitment domains (CARDs). We discovered that MERS-CoV N protein suppresses RIG-I-CARD-, but not MDA5-CARD-induced IFN-β and IFN-λ1 promoter activity. By interacting with TRIM25, N protein impedes RIG-I ubiquitination and activation and inhibits the phosphorylation of transcription factors IFN-regulatory factor 3 (IRF3) and NF-κB that are known to be important for IFN gene activation. By employing recombinant Sindbis virus-EGFP replication system, we showed that viral N protein downregulated the production of not only IFN mRNA but also bioactive IFN proteins. Taken together, MERS-CoV N protein functions as an IFN antagonist. It suppresses RIG-I-induced type I and type III IFN production by interfering with TRIM25-mediated RIG-I ubiquitination. Our study sheds light on the pathogenic mechanism of how MERS-CoV causes disease.<b>IMPORTANCE</b>
MERS-CoV causes death of about 35% of patients. Published studies showed that some coronaviruses are capable of suppressing interferon (IFN) expression in the early phase of infection and MERS-CoV proteins can modulate host immune response. In this study, we demonstrated that MERS-CoV nucleocapsid (N) protein suppresses the production of both type I and type III IFNs via sequestering TRIM25, an E3 ubiquitin ligase that is essential for activating RIG-I signaling pathway. Ectopic expression of TRIM25 rescues the suppressive effect of the N protein. In addition, the C-terminal domain of the viral N protein plays a pivotal role in the suppression of IFN-β promoter activity. Our findings reveal how MERS-CoV evades innate immunity and provide insights into the interplay between host immune response and viral pathogenicity.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32295922</PMID>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Apr</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Middle East respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">JVI.00099-20</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00099-20</ELocationID>
<Abstract><AbstractText>Type I and type III interferons (IFNs) are the frontlines of antiviral defense mechanism that trigger hundreds of downstream antiviral genes. In this study, we observed that MERS-CoV nucleocapsid (N) protein suppresses type I and III IFN gene expression. The N protein suppresses Sendai virus-induced IFN-β and IFN-λ1 by reducing their promoter activity and mRNA levels as well as downstream IFN stimulated genes (ISGs). Retinoic acid-inducible gene-I (RIG-I) is known to recognize viral RNA and induce IFN expression through tripartite motif-containing protein 25 (TRIM25)-mediated ubiquitination of RIG-I caspase activation and recruitment domains (CARDs). We discovered that MERS-CoV N protein suppresses RIG-I-CARD-, but not MDA5-CARD-induced IFN-β and IFN-λ1 promoter activity. By interacting with TRIM25, N protein impedes RIG-I ubiquitination and activation and inhibits the phosphorylation of transcription factors IFN-regulatory factor 3 (IRF3) and NF-κB that are known to be important for IFN gene activation. By employing recombinant Sindbis virus-EGFP replication system, we showed that viral N protein downregulated the production of not only IFN mRNA but also bioactive IFN proteins. Taken together, MERS-CoV N protein functions as an IFN antagonist. It suppresses RIG-I-induced type I and type III IFN production by interfering with TRIM25-mediated RIG-I ubiquitination. Our study sheds light on the pathogenic mechanism of how MERS-CoV causes disease.<b>IMPORTANCE</b>
MERS-CoV causes death of about 35% of patients. Published studies showed that some coronaviruses are capable of suppressing interferon (IFN) expression in the early phase of infection and MERS-CoV proteins can modulate host immune response. In this study, we demonstrated that MERS-CoV nucleocapsid (N) protein suppresses the production of both type I and type III IFNs via sequestering TRIM25, an E3 ubiquitin ligase that is essential for activating RIG-I signaling pathway. Ectopic expression of TRIM25 rescues the suppressive effect of the N protein. In addition, the C-terminal domain of the viral N protein plays a pivotal role in the suppression of IFN-β promoter activity. Our findings reveal how MERS-CoV evades innate immunity and provide insights into the interplay between host immune response and viral pathogenicity.</AbstractText>
<CopyrightInformation>Copyright © 2020 American Society for Microbiology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName>
<ForeName>Chi-You</ForeName>
<Initials>CY</Initials>
<AffiliationInfo><Affiliation>Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Helene Minyi</ForeName>
<Initials>HM</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-4837-5373</Identifier>
<AffiliationInfo><Affiliation>Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chang</LastName>
<ForeName>Ming-Fu</ForeName>
<Initials>MF</Initials>
<AffiliationInfo><Affiliation>Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan mfchang@ntu.edu.tw.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chang</LastName>
<ForeName>Shin C</ForeName>
<Initials>SC</Initials>
<AffiliationInfo><Affiliation>Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan scchang093@ntu.edu.tw.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32295922</ArticleId>
<ArticleId IdType="pii">JVI.00099-20</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.00099-20</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000017 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000017 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:32295922 |texte= Middle East respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32295922" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
This area was generated with Dilib version V0.6.33. |